NCT00348023已完成4 期
Comparison of Bimatoprost 0.03% Monotherapy vs. Dual Therapy With Travoprost 0.004% and Timolol 0.5% in Patients With Glaucoma and Ocular Hypertension
适应症
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 试验地点
- 2
研究概览
简要总结
Evaluate the IOP-lowering efficacy and quality of life in patients using bimatoprost 0.03% monotherapy versus dual therapy with travoprost 0.004% and timolol 0.5% for the treatment of glaucoma or ocular hypertension.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 盲法
- Single
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •· Male or female > 18 years of age
- •Diagnosis of primary open-angle glaucoma or ocular hypertension
- •Untreated IOP > 18 mm Hg in each eye at the baseline evaluation
- •Ability to provide informed consent and likely to complete all study visits
排除标准
- •· Known contraindication to bimatoprost, travoprost, timolol, or any component of any study medication
- •Uncontrolled systemic disease
- •Active ocular disease other than POAG or ocular hypertension
- •Required use of ocular medications other than the study medications during the study (intermittent use of OTC artificial tear products will be permitted)
- •History of intraocular surgery within the last 3 months
- •Patient must not have discontinued use of any medication included in this study in the past for reasons of efficacy or intolerance
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
A Study Comparing IOP-Lowering Treatments to Bimatoprost in Patients With Primary Open Angle Glaucoma or Ocular HypertensionGlaucoma, Open-AngleOcular HypertensionNCT01646151Allergan2,580
已完成
4 期
Efficacy of Bimatoprost 0.03% in Patients Who Are Low-Responders to LatanoprostGlaucomaNCT00347841Innovative Medical
进行中（未招募）
不适用
Comparison between the effects on ocular pressure of Bimatoprost 0.01% and Timolol 0.5% during the day and nightglaucoma and ocular hypertensionMedDRA version: 14.1Level: PTClassification code 10030348Term: Open angle glaucomaSystem Organ Class: 10015919 - Eye disordersEUCTR2010-024272-26-ITIRCCS- FONDAZIONE G.B. BIETTI PER LO STUDIO E LA RICERCA IN OFTALMOLOGIA-ONLUS
已完成
4 期
24-hour IOP-lowering Effect of 0.01% BimatoprostIntraocular PressureGlaucomaOcular HypertensionNCT01271686University of California, San Diego16
已完成
不适用
Safety and Efficacy Study of Bimatoprost, Latanoprost, and Travoprost in Patients With Elevated Intraocular Pressure (IOP) and Open-angle Glaucoma (OAG)Ocular HypertensionOpen-Angle GlaucomaNCT00716742Allergan1,099